Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
30.42
-0.23 (-0.75%)
At close: Mar 3, 2026, 4:00 PM EST
30.35
-0.07 (-0.23%)
After-hours: Mar 3, 2026, 7:39 PM EST
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $542.43 million as of March 3, 2026. Its market cap has increased by 660.93% in one year.
Market Cap
542.43M
Enterprise Value
449.02M
1-Year Change
660.93%
Ranking
Category
Stock Price
$30.42
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $542.43M, an increase of 198.97%. That is a compound annual growth rate of 21.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 546.53M | 12.39% |
| Dec 31, 2025 | 486.26M | 234.91% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Larimar Therapeutics | 576.61M |
| CorMedix | 561.77M |
| Contineum Therapeutics | 560.36M |
| Fulcrum Therapeutics | 558.11M |
| Rocket Pharmaceuticals | 543.93M |
| Altimmune | 539.75M |
| Vanda Pharmaceuticals | 526.65M |
| Lexeo Therapeutics | 524.05M |